M&A Deal Summary

Meda Acquires Alaven Pharmaceuticals

On October 5, 2010, Meda acquired life science company Alaven Pharmaceuticals from DFW Capital Partners and Greyrock Capital Group for 350M USD

Acquisition Highlights
  • This is Meda’s 4th transaction in the Life Science sector.
  • This is Meda’s 5th largest (disclosed) transaction.
  • This is Meda’s 2nd transaction in the United States.
  • This is Meda’s 1st transaction in Georgia.

M&A Deal Summary

Date 2010-10-05
Target Alaven Pharmaceuticals
Sector Life Science
Buyer(s) Meda
Sellers(s) DFW Capital Partners
Greyrock Capital Group
Deal Type Add-on Acquisition
Deal Value 350M USD

Target

Alaven Pharmaceuticals

Marietta, Georgia, United States
Alaven Pharmaceutical LLC is a specialty pharmaceutical company, develops and markets prescription and non-prescription products that treat women’s health, gastroenterology, and anemia conditions in the United States.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Meda

Solna, Sweden

Category Company
Sector Life Science
Revenue 19.6B SEK (2015)
DESCRIPTION

Meda is an operator of an international specialty pharma company that is fully represented in Europe and the US through its own sales organizations in more than 50 countries. Meda’s products are sold in about 120 countries, and where it lacks a sales organization, it markets and sells its products via agents and other pharmaceutical companies. Meda has a diversified geographic footprint with approximately 62 percent of Meda's sales generated in Western Europe (the largest countries being Italy, Germany, France, and Sweden), 19 percent in Emerging Markets (driven by China, Russia, the Middle East, and Thailand) and 17 percent in the U.S. Meda has a network of seven manufacturing facilities in Europe, the U.S. and India. Meda is based in Solna, Sweden.


DEAL STATS #
Overall 4 of 7
Sector (Life Science) 4 of 6
Type (Add-on Acquisition) 4 of 7
State (Georgia) 1 of 1
Country (United States) 2 of 3
Year (2010) 1 of 1
Size (of disclosed) 5 of 7
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-07-20 MedPointe Pharmaceuticals

Somerset, New Jersey, United States

MedPointe, Inc. develops, manufactures and markets a broad range of branded prescription specialty pharmaceutical products in the U.S.

Buy $800M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-04-21 Healthcare Brands International

London, United Kingdom

Healthcare Brands International is focused on acquiring, developing and investing in differentiated healthcare products to translate innovative science into meaningful consumer brands. HBI owns Antula, the leading independent OTC pharmaceutical company in the Nordic region.

Buy kr1.8B

Seller(S) 2

SELLER

DFW Capital Partners

New York, New Jersey, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1983
PE ASSETS 600M USD
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

DFW Capital Partners is a private equity firm that invests in high-growth middle-market service companies generating revenues up to $200 million. Specific service areas of interest include business services, industrial services, and healthcare services. Prospective transactions include growth capital financing, acquisition financing, management buyouts, and recapitalization. DFW will not invest in start-ups, real estate, or pure R&D companies. DFW Capital Partners was formed in 1983 and is based in Teaneck, New Jersey.


DEAL STATS #
Overall 11 of 26
Sector (Life Science) 2 of 4
Type (Add-on Acquisition) 6 of 13
State (Georgia) 2 of 3
Country (United States) 11 of 26
Year (2010) 1 of 1
Size (of disclosed) 2 of 8
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-09-30 MNG Health

Bensalem, Pennsylvania, United States

MNG Health is a provider of technology-enabled multi-channel marketing solutions that allow pharmaceutical, biotechnology, and medical device brands. MNG Health was founded in 2013 and is based in Bensalem, Pennsylvania.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-01-01 Covenant Physician Partners

Nashville, Tennessee, United States

Covenant Physician Partners is an operator of ambulatory surgery centers, physician practices, and ancillary services with a particular focus on gastroenterology and ophthalmology end markets. Covenant Physician Partners was founded in 2008 and is based in Nashville, Tennessee.

Buy -
SELLER

Greyrock Capital Group

Walnut Creek, California, United States

Investor Investor Investor Investor Investor


Category Mezzanine Finance Firm
Founded 2002
PE ASSETS 350M USD
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

Greyrock Capital Group provides mezzanine debt and equity capital to finance buyouts, recapitalizations and growth needs of middle market companies. Greyrock looks to invest between $8 and $40 million of equity and/or junior capital in companies with minimum revenues of $10 million and at least $2 million of EBITDA. Greyrock prefers companies in defensible markets with low cost structures. Greyrock Capital was formed in 2002 and has offices in San Francisco, California; Chicago, Illinois; and Westport, Connecticut.


DEAL STATS #
Overall 8 of 45
Sector (Life Science) 1 of 2
Type (Add-on Acquisition) 6 of 23
State (Georgia) 2 of 3
Country (United States) 8 of 45
Year (2010) 1 of 1
Size (of disclosed) 4 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-08-02 DecisionQuest

Torrance, California, United States

DecisionQuest is a litigation support services firms, specializing in trial consulting, demonstrative exhibits, courtroom technology and social media analysis. DecisionQuest was founded in 1991 and is based in Torrance, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-05-01 Dickinson Frozen Foods

Eagle, Idaho, United States

Dickinson Frozen Foods, Inc. is a provider of frozen roasted potatoes, onions and vegetable blends to large industrial food processors and food service companies.

Sell -